Israel will begin easing locking restrictions, the opening of shops and cultural facilities, following the rapid decline of new infections among its vaccinated elderly population. The coronavirus cabinet voted to reopen some places such as shopping malls to the general public, while restricting access to gyms, hotels and cinemas to those who can show evidence of vaccination.
Boris Johnson, the Prime Minister of the United Kingdom, said that he did not rule out the possibility that people could be reached domestic “vaccine passports”. “We will look at everything,” he said when asked about the possible use of documentation. Johnson said he preferred to use a combination of vaccinations and rapid lateral flow tests.
The first passengers arrived at airport hotels in Great Britain to start the 10-day isolation stricter quarantine measures entered into force with the aim of limiting the spread of more dangerous variants of coronavirus. The Radisson Blu at Heathrow was among the hotels that accepted a small number of passengers coming from high-risk countries on Monday morning.
The EU’s anti-fraud office has warned governments to be wary of sales schemes fake Covid-19 vaccine while its member states are trying to make up for the initial slow introduction of the vaccine. “We hear reports of fraudsters offering to sell vaccines to governments across the EU,” said Ville Itälä, director general of the European Anti-Fraud Office.
Mitchells & Butlers, Britain’s largest pub company on the list, plans to raise £ 350m through a stake severely affected industry pressures the government to determine when the seats will be able to reopen. The group, which owns the Harvester and All Bar One brands, said it would offer 167 million new shares with a 36 percent discount on Friday’s closing price.
Pascal Soriot, CEO of AstraZeneca, received the same salary growth as the company’s employees, in which he oversaw the launch of one of the world’s most important promising coronavirus vaccines. Soriot received a base salary of £ 1.29 million, an annual bonus of £ 2.3 million and payments under a long-term incentive program worth £ 11.1 million for 2020.
Novavax, one of unexpected success stories vaccine race against Covid-19, is preparing to complete enrollment in the United States in record time, which is another step closer to fulfilling the order to inoculate 50 million Americans. Thirty-year-old biotechnology – which has never successfully launched a drug on the market before – has enrolled nearly 30,000 participants in the U.S. trial.
PensionBee, the launch of financial technology in the UK, will enable buyers to become shareholders according to plans to be listed on the London Stock Exchange. In 2020, PensionBee reported a 77 percent increase in revenue to £ 6.3 million, with growth driven by more people relying on online channels manage your money during a pandemic.